Bio-orthogonal drug activation

作者: Ronny Mathieu Versteegen , Marc Stefan Robillard , Hendricus Marie Janssen , Wolter ten Hoeve

DOI:

关键词:

摘要: The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. also kit comprising at least one and Activator, the comprises Drug first Bio-orthogonal Reactive Group (the Trigger), Activator second Group. targeted therapeutics used in above-mentioned method kit. particularly pertains antibody-drug conjugates bi- trispecific antibody derivatives.

参考文章(56)
Melissa Blackman, Peter S. Conti, Ramajeyam Selvaraj, Zibo Li, Joseph M. Fox, Matthew Hassink, Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes ,(2011)
Melissa Blackman, Joseph Michael Fox, Maksim Royzen, Ni Yan, Tetrazine-based bio-orthogonal coupling reagents and methods ,(2008)
Lawrence G Lum, Archana Thakur, Cancer therapy with bispecific antibodies: Clinical experience. Current Opinion in Molecular Therapeutics. ,vol. 12, pp. 340- 349 ,(2010)
Johan Lub, Sandra Martina Van Den Bosch, Raffaella Rossin, Ronny Mathieu Versteegen, Marc Stefan Robillard, Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene ,(2012)